Valkai
Valkai provides an AI operating system and agent systems for life sciences, connecting data and AI agents to streamline pharmaceutical, biotech and medical device workflows.
Valkai builds an AI operating system purpose-built for life sciences, deploying agent systems across pharmaceutical, biotechnology and medical device workflows. The Valkai AI Operating System connects internal data, industry sources and AI agents into a single coordinated layer spanning the full development pipeline - from discovery through clinical development, regulatory affairs, medical writing and quality assurance. The company reports more than 20,000 users across top pharmaceutical companies.
The technical work spans AI agents and agent systems, AI operating-system design, data integration and orchestration, and building for regulated AI environments where security, compliance and data privacy are central constraints. Valkai's stated aim is to compress work that took months into weeks; the company notes that a typical drug-development timeline in the industry runs to ten or more years from discovery to market, and positions its platform as a way to reduce development timelines and remove operational barriers to scientific progress.
The company is built by leaders from premier AI labs and life sciences companies and operates in regulated settings throughout. Its industry verticals include pharmaceutical, biotechnology, medical devices and life sciences more broadly.